|
Notice to Readers: Update on Spectinomycin Availability in the
United States
In April 2001, Pharmacia Corporation (Peapack, New Jersey) announced
the discontinuation of its U.S. production of spectinomycin
(Trobicin®)* and that its remaining inventory would expire on June 30, 2001
(1). Since then, examination of the inventory has revealed that, although some lots of the bacteriostatic water
packaged with the spectinomycin have expired, the spectinomycin powder has a
shelf-life beyond June 30. The Food and Drug Administration has approved
Pharmacia's request to remove the bacteriostatic water and to relabel the current inventory
of spectinomycin to expire on December 31. To obtain spectinomycin or to
verify whether a spectinomycin lot may continue to be used, contact Wendy
Johnson, Pharmacia Corporation, telephone (800) 976-7741, extension 30110; fax (800)
852-6421.
Pharmacia is planning to resume U.S. spectinomycin production later in
2001. When new spectinomycin is available, it will be distributed again through the
usual wholesale distribution network.
Reference†
- CDC. Shortage of spectinomycin---United States. MMWR
2001;50:470.
* Use of trade names is for identification only and does not imply endorsement by CDC
or the U.S. Department of Health and Human Services.
† All MMWR references are available on the Internet at <http://www.cdc.gov/mmwr>.
Use the search function to find specific articles.
Disclaimer
All MMWR HTML versions of articles are electronic conversions from ASCII text
into HTML. This conversion may have resulted in character translation or format errors in the HTML version.
Users should not rely on this HTML document, but are referred to the electronic PDF version and/or
the original MMWR paper copy for the official text, figures, and tables.
An original paper copy of this issue can be obtained from the Superintendent of Documents,
U.S. Government Printing Office (GPO), Washington, DC 20402-9371; telephone: (202) 512-1800.
Contact GPO for current prices.
**Questions or messages regarding errors in formatting should be addressed to
mmwrq@cdc.gov.
Page converted: 8/3/2001
|
|
